SSH - NORTHEAST NEW JERSEY INC. — History
CCN 312019 | 3-year financial timeline | COVID resilience: 58/100
🛡️ Public data only — no PHI permitted on this instance.
$30M
Latest Revenue (FY2022)
+12.5%
Revenue CAGR (3yr)
1.8%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $24M | $24M | $30M | +22.2% | +12.5% |
| Operating Expenses | $22M | $19M | $29M | +53.1% | +15.2% |
| Operating Margin | 6.4% | 21.6% | 1.8% | -91.6% | -46.9% |
| Net Income | $2M | $5M | $1M | -89.7% | -40.3% |
| Licensed Beds | 62 | 62 | 62 | +0.0% | +0.0% |
| Total Patient Days | 9,076 | 9,015 | 11,509 | +27.7% | +12.6% |
| Medicare Day % | 52% | 57% | 51% | -10.7% | -1.2% |
| Medicaid Day % | 1% | 0% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 58/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +26.5% ($24M → $30M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+12.5%
This Hospital
+7.6%
State Avg
Latest Margin
1.8%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $33M | -0.5% |
| FY2024 (proj) | $36M | -2.8% |
| FY2025 (proj) | $39M | -5.1% |